Resona Asset Management Co. Ltd. Invests $300,000 in Maximus, Inc. (NYSE:MMS)

Resona Asset Management Co. Ltd. purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,019 shares of the health services provider's stock, valued at approximately $300,000.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after purchasing an additional 205,564 shares in the last quarter. Geode Capital Management LLC raised its holdings in Maximus by 1.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock worth $142,109,000 after acquiring an additional 21,532 shares during the last quarter. Van Berkom & Associates Inc. lifted its position in Maximus by 8.5% in the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after acquiring an additional 98,264 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after purchasing an additional 71,598 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Maximus in the 4th quarter worth $71,443,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Remove Ads

Maximus Stock Performance

MMS traded down $0.56 during mid-day trading on Tuesday, reaching $68.18. 324,215 shares of the company traded hands, compared to its average volume of 548,017. The company's fifty day moving average price is $67.75 and its 200-day moving average price is $75.87. The stock has a market capitalization of $3.86 billion, a P/E ratio of 14.66 and a beta of 0.68. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. Maximus's dividend payout ratio is currently 25.81%.

Insiders Place Their Bets

In other news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.